On July 6, 2022 ReCode Therapeutics, a genetic medicines company using superior delivery to power the next wave of mRNA and gene correction therapeutics, reported that Company leadership will participate in two upcoming investor conferences in July (Press release, ReCode Therapeutics, JUL 6, 2022, View Source;utm_medium=rss&utm_campaign=recode-therapeutics-to-participate-in-upcoming-july-investor-conferences [SID1234619534]):

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

William Blair Biotech Focus Conference (New York, NY)
Format: Panel Presentation
Date: Wednesday, July 13, 2022
Time: 2:00 – 2:45 p.m. ET
Cowen RNA Therapeutics Summit (Virtual)
Format: Panel Presentation
Date: Thursday, July 21, 2022
Time: 12:55 – 1:40 p.m. ET